Industry Research Reports
Global Biodegradable Gastrointestinal Stents Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-11-02
Pages: 178 Pages
Report ld: 5344218
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Biodegradable Gastrointestinal Stents Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 36,170
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biodegradable Gastrointestinal Stents market is projected to grow from US$ 25660 million in 2024 to US$ 36170 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Biodegradable gastrointestinal stents are a promising alternative to permanent stents, made of biodegradable materials such as polyesters, polycarbonates, bacteria-derived polymers, and corroded metals. It may eventually be used to address the long-standing problem of in-stent restenosis. In addition, fully degradable stents are able to deliver more drug to the target site than thin drug coatings on metal stents. Biodegradable gastrointestinal stents are gradually absorbed by the gastrointestinal system, and they help maintain the patency of the gastrointestinal tract for a predetermined period of time.
Stent manufacturers are also focusing on product development due to numerous medical advancements and studies of diagnostic technology upgrades, as well as increasing demand for minimally invasive surgical treatments, utilizing smartphone applications, and more market penetration of products. Other factors expected to drive market growth include implementation of favorable government policies, significant expansion of healthcare infrastructure, extensive research and development efforts, and growing focus of diagnostic laboratories on adopting advanced technologies. According to the World Health Organization (WHO), colorectal cancer was responsible for more than 1.9 million new cases and more than 930,000 deaths worldwide in 2020. By 2040, there will be 3.2 million new cases of colorectal cancer per year (63% increase) and 1.6 million annual deaths (73% increase). Rising prevalence of cancer, rising demand for minimally invasive surgical procedures, development of advanced diagnostic techniques, and rising disposable income are all factors contributing to the growth of the global market over the forecast period.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Biodegradable Gastrointestinal Stents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Boston Scientific
- Cook Group
- Micro-Tech
- Taewoong Medical
- Olympus
- Merit Medical System
- BD
- ELLA-CS
- Medtronic
- BVM Medical
- ConMed
- C.R. Bard
- Endo-Flex
- Cantel Medical
- Hobbs Medical
- M.I. Tech
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Biliary Stents
- Duodenal Stents
- Colonic Stents
- Pancreatic Stents
- Esophageal Stents
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Centers
CHAPTER OUTLINE
Chapter 1: Defines the Biodegradable Gastrointestinal Stents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Biodegradable Gastrointestinal Stents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biodegradable Gastrointestinal Stents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Biliary Stents
1.2.3 Duodenal Stents
1.2.4 Colonic Stents
1.2.5 Pancreatic Stents
1.2.6 Esophageal Stents
1.3 Market Segmentation by Application
1.3.1 Global Biodegradable Gastrointestinal Stents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biodegradable Gastrointestinal Stents Revenue Estimates and Forecasts 2020-2031
2.2 Global Biodegradable Gastrointestinal Stents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biodegradable Gastrointestinal Stents Sales Estimates and Forecasts 2020-2031
2.4 Global Biodegradable Gastrointestinal Stents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Biodegradable Gastrointestinal Stents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Biodegradable Gastrointestinal Stents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Biliary Stents Market Size by Manufacturers
3.5.2 Duodenal Stents Market Size by Manufacturers
3.5.3 Colonic Stents Market Size by Manufacturers
3.5.4 Pancreatic Stents Market Size by Manufacturers
3.5.5 Esophageal Stents Market Size by Manufacturers
3.6 Global Biodegradable Gastrointestinal Stents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Biodegradable Gastrointestinal Stents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Biodegradable Gastrointestinal Stents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Biodegradable Gastrointestinal Stents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Biodegradable Gastrointestinal Stents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Biodegradable Gastrointestinal Stents Sales and Revenue by Type (2020-2031)
6.4 North America Biodegradable Gastrointestinal Stents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Biodegradable Gastrointestinal Stents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Biodegradable Gastrointestinal Stents Sales and Revenue by Type (2020-2031)
7.4 Europe Biodegradable Gastrointestinal Stents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Biodegradable Gastrointestinal Stents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Biodegradable Gastrointestinal Stents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Biodegradable Gastrointestinal Stents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Biodegradable Gastrointestinal Stents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Biodegradable Gastrointestinal Stents Sales and Revenue by Type (2020-2031)
9.4 Central and South America Biodegradable Gastrointestinal Stents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Biodegradable Gastrointestinal Stents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Biodegradable Gastrointestinal Stents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Biodegradable Gastrointestinal Stents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Biodegradable Gastrointestinal Stents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Boston Scientific
11.1.1 Boston Scientific Corporation Information
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.1.4 Boston Scientific Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Boston Scientific Biodegradable Gastrointestinal Stents Sales by Product in 2024
11.1.6 Boston Scientific Biodegradable Gastrointestinal Stents Sales by Application in 2024
11.1.7 Boston Scientific Biodegradable Gastrointestinal Stents Sales by Geographic Area in 2024
11.1.8 Boston Scientific Biodegradable Gastrointestinal Stents SWOT Analysis
11.1.9 Boston Scientific Recent Developments
11.2 Cook Group
11.2.1 Cook Group Corporation Information
11.2.2 Cook Group Business Overview
11.2.3 Cook Group Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.2.4 Cook Group Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cook Group Biodegradable Gastrointestinal Stents Sales by Product in 2024
11.2.6 Cook Group Biodegradable Gastrointestinal Stents Sales by Application in 2024
11.2.7 Cook Group Biodegradable Gastrointestinal Stents Sales by Geographic Area in 2024
11.2.8 Cook Group Biodegradable Gastrointestinal Stents SWOT Analysis
11.2.9 Cook Group Recent Developments
11.3 Micro-Tech
11.3.1 Micro-Tech Corporation Information
11.3.2 Micro-Tech Business Overview
11.3.3 Micro-Tech Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.3.4 Micro-Tech Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Micro-Tech Biodegradable Gastrointestinal Stents Sales by Product in 2024
11.3.6 Micro-Tech Biodegradable Gastrointestinal Stents Sales by Application in 2024
11.3.7 Micro-Tech Biodegradable Gastrointestinal Stents Sales by Geographic Area in 2024
11.3.8 Micro-Tech Biodegradable Gastrointestinal Stents SWOT Analysis
11.3.9 Micro-Tech Recent Developments
11.4 Taewoong Medical
11.4.1 Taewoong Medical Corporation Information
11.4.2 Taewoong Medical Business Overview
11.4.3 Taewoong Medical Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.4.4 Taewoong Medical Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Taewoong Medical Biodegradable Gastrointestinal Stents Sales by Product in 2024
11.4.6 Taewoong Medical Biodegradable Gastrointestinal Stents Sales by Application in 2024
11.4.7 Taewoong Medical Biodegradable Gastrointestinal Stents Sales by Geographic Area in 2024
11.4.8 Taewoong Medical Biodegradable Gastrointestinal Stents SWOT Analysis
11.4.9 Taewoong Medical Recent Developments
11.5 Olympus
11.5.1 Olympus Corporation Information
11.5.2 Olympus Business Overview
11.5.3 Olympus Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.5.4 Olympus Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Olympus Biodegradable Gastrointestinal Stents Sales by Product in 2024
11.5.6 Olympus Biodegradable Gastrointestinal Stents Sales by Application in 2024
11.5.7 Olympus Biodegradable Gastrointestinal Stents Sales by Geographic Area in 2024
11.5.8 Olympus Biodegradable Gastrointestinal Stents SWOT Analysis
11.5.9 Olympus Recent Developments
11.6 Merit Medical System
11.6.1 Merit Medical System Corporation Information
11.6.2 Merit Medical System Business Overview
11.6.3 Merit Medical System Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.6.4 Merit Medical System Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Merit Medical System Recent Developments
11.7 BD
11.7.1 BD Corporation Information
11.7.2 BD Business Overview
11.7.3 BD Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.7.4 BD Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 BD Recent Developments
11.8 ELLA-CS
11.8.1 ELLA-CS Corporation Information
11.8.2 ELLA-CS Business Overview
11.8.3 ELLA-CS Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.8.4 ELLA-CS Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 ELLA-CS Recent Developments
11.9 Medtronic
11.9.1 Medtronic Corporation Information
11.9.2 Medtronic Business Overview
11.9.3 Medtronic Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.9.4 Medtronic Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Medtronic Recent Developments
11.10 BVM Medical
11.10.1 BVM Medical Corporation Information
11.10.2 BVM Medical Business Overview
11.10.3 BVM Medical Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.10.4 BVM Medical Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 BVM Medical Recent Developments
11.11 ConMed
11.11.1 ConMed Corporation Information
11.11.2 ConMed Business Overview
11.11.3 ConMed Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.11.4 ConMed Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 ConMed Recent Developments
11.12 C.R. Bard
11.12.1 C.R. Bard Corporation Information
11.12.2 C.R. Bard Business Overview
11.12.3 C.R. Bard Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.12.4 C.R. Bard Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 C.R. Bard Recent Developments
11.13 Endo-Flex
11.13.1 Endo-Flex Corporation Information
11.13.2 Endo-Flex Business Overview
11.13.3 Endo-Flex Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.13.4 Endo-Flex Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Endo-Flex Recent Developments
11.14 Cantel Medical
11.14.1 Cantel Medical Corporation Information
11.14.2 Cantel Medical Business Overview
11.14.3 Cantel Medical Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.14.4 Cantel Medical Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Cantel Medical Recent Developments
11.15 Hobbs Medical
11.15.1 Hobbs Medical Corporation Information
11.15.2 Hobbs Medical Business Overview
11.15.3 Hobbs Medical Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.15.4 Hobbs Medical Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Hobbs Medical Recent Developments
11.16 M.I. Tech
11.16.1 M.I. Tech Corporation Information
11.16.2 M.I. Tech Business Overview
11.16.3 M.I. Tech Biodegradable Gastrointestinal Stents Product Models, Descriptions and Specifications
11.16.4 M.I. Tech Biodegradable Gastrointestinal Stents Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 M.I. Tech Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Biodegradable Gastrointestinal Stents Industry Chain
12.2 Biodegradable Gastrointestinal Stents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Biodegradable Gastrointestinal Stents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Biodegradable Gastrointestinal Stents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Biodegradable Gastrointestinal Stents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Biodegradable Gastrointestinal Stents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
Biodegradable Gastrointestinal Stents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biodegradable Gastrointestinal Stents was estimated to be worth US$ 26840 million in 2025 and is projected to reach US$ 37830 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 150
USD 3950.00
(Single User License)
Global Biodegradable Gastrointestinal Stents Market Research Report 2026
The global Biodegradable Gastrointestinal Stents market was valued at US$ 26840 million in 2025 and is anticipated to reach US$ 37830 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 131
USD 2900.00
(Single User License)
Global Biodegradable Gastrointestinal Stents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biodegradable Gastrointestinal Stents market size was US$ 25660 million in 2024 and is forecast to a readjusted size of US$ 36170 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 102
USD 4250.00
(Single User License)
Global Biodegradable Gastrointestinal Stents Market Research Report 2025
The global market for Biodegradable Gastrointestinal Stents was valued at US$ 25660 million in the year 2024 and is projected to reach a revised size of US$ 36170 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-16
Pages: 101
USD 2900.00
(Single User License)
Biodegradable Gastrointestinal Stents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biodegradable Gastrointestinal Stents was estimated to be worth US$ 25660 million in 2024 and is forecast to a readjusted size of US$ 36170 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 133
USD 3950.00
(Single User License)
Global Biodegradable Gastrointestinal Stents Market Research Report 2024
Biodegradable gastrointestinal stents are a promising alternative to permanent stents, made of biodegradable materials such as polyesters, polycarbonates, bacteria-derived polymers, and corroded metals. It may eventually be used to address the long-standing problem of in-stent restenosis. In addition, fully degradable stents are able to deliver more drug to the target site than thin drug coatings on metal stents. Biodegradable gastrointestinal stents are gradually absorbed by the gastrointestinal system, and they help maintain the patency of the gastrointestinal tract for a predetermined period of time.
Published Date: 2024-01-20
Pages: 98
USD 2900.00
(Single User License)
Biodegradable Gastrointestinal Stents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biodegradable gastrointestinal stents are a promising alternative to permanent stents, made of biodegradable materials such as polyesters, polycarbonates, bacteria-derived polymers, and corroded metals. It may eventually be used to address the long-standing problem of in-stent restenosis. In addition, fully degradable stents are able to deliver more drug to the target site than thin drug coatings on metal stents. Biodegradable gastrointestinal stents are gradually absorbed by the gastrointestinal system, and they help maintain the patency of the gastrointestinal tract for a predetermined period of time.
Published Date: 2024-01-11
Pages: 142
USD 3950.00
(Single User License)
Biodegradable Gastrointestinal Stents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Biodegradable Gastrointestinal Stents was estimated to be worth US$ 26840 million in 2025 and is projected to reach US$ 37830 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 150
USD 3950.00 (Single User License)Global Biodegradable Gastrointestinal Stents Market Research Report 2026
The global Biodegradable Gastrointestinal Stents market was valued at US$ 26840 million in 2025 and is anticipated to reach US$ 37830 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 131
USD 2900.00 (Single User License)Global Biodegradable Gastrointestinal Stents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Biodegradable Gastrointestinal Stents market size was US$ 25660 million in 2024 and is forecast to a readjusted size of US$ 36170 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 102
USD 4250.00 (Single User License)Global Biodegradable Gastrointestinal Stents Market Research Report 2025
The global market for Biodegradable Gastrointestinal Stents was valued at US$ 25660 million in the year 2024 and is projected to reach a revised size of US$ 36170 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-16
Pages: 101
USD 2900.00 (Single User License)Biodegradable Gastrointestinal Stents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Biodegradable Gastrointestinal Stents was estimated to be worth US$ 25660 million in 2024 and is forecast to a readjusted size of US$ 36170 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 133
USD 3950.00 (Single User License)Global Biodegradable Gastrointestinal Stents Market Research Report 2024
Biodegradable gastrointestinal stents are a promising alternative to permanent stents, made of biodegradable materials such as polyesters, polycarbonates, bacteria-derived polymers, and corroded metals. It may eventually be used to address the long-standing problem of in-stent restenosis. In addition, fully degradable stents are able to deliver more drug to the target site than thin drug coatings on metal stents. Biodegradable gastrointestinal stents are gradually absorbed by the gastrointestinal system, and they help maintain the patency of the gastrointestinal tract for a predetermined period of time.
Published: 2024-01-20
Pages: 98
USD 2900.00 (Single User License)Biodegradable Gastrointestinal Stents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Biodegradable gastrointestinal stents are a promising alternative to permanent stents, made of biodegradable materials such as polyesters, polycarbonates, bacteria-derived polymers, and corroded metals. It may eventually be used to address the long-standing problem of in-stent restenosis. In addition, fully degradable stents are able to deliver more drug to the target site than thin drug coatings on metal stents. Biodegradable gastrointestinal stents are gradually absorbed by the gastrointestinal system, and they help maintain the patency of the gastrointestinal tract for a predetermined period of time.
Published: 2024-01-11
Pages: 142
USD 3950.00 (Single User License)
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now